Inclisiran

2 FDA-DMF suppliersOligonucleotide

Overview

Inclisiran is a oligonucleotide active pharmaceutical ingredient (ChEMBL CHEMBL3990033).

API suppliers (2)

Suppliers of Inclisiran backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • HANGZHOU APEXTIDE BIOMEDICAL TECHNOLOGY CO LTDChina1 active DMF
  • SUZHOU OLIPHARMA CO LTDChina1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Inclisiran expires 25 Aug 2036 and exclusivity 12 Feb 2029. Generic API sourcing typically opens up once these lapse.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo